"Venous thromboembolism (VTE)"- Market Insights, Epidemiology and Market Forecast-2020

  • ID: 3645159
  • Drug Pipelines
  • Region: Global
  • 70 pages
  • DelveInsight
UP TO OFF
until Dec 31st 2018
1 of 3
This Venous thromboembolism (VTE) - Market Insights, Epidemiology and Market Forecast-2020” report provides an overview of the disease and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Venous thromboembolism (VTE) forecasted market share for ten years to 2020 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Venous thromboembolism (VTE) till 2020.

Key Coverage and Benefits

- The report will help in developing business strategies by understanding the trends shaping and driving the global Venous thromboembolism (VTE) market.
- Identifying patient populations in the global “Venous thromboembolism (VTE)market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the best opportunities for Venous thromboembolism (VTE) therapeutics in each of the markets covered.
- To understand the future market competition in the global Venous thromboembolism (VTE) therapeutics market and Insightful review of the key market drivers and barriers.

Scope

- Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
- Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
- The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.
- It also provides Venous thromboembolism (VTE) for United States, EU5 and Japan from 2010 and forecasted Market to 2020.

Note*: This report requires 2 business days to complete.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
Table of Contents

- Venous thromboembolism (VTE) overview
- Pathophysiology
- Symptoms of disease
- Etiology of disease
- Diagnosis of disease
- Treatment of disease
- Overview of Marketed drugs
- Drug Description
- Mechanism of Action
- Pharmacokinetics Properties
- Marketed Details
- Patent Information
- Patent Exclusivity Expiry Assessment United States (US)
- Patents Details
- Historical and Forecasted sales of marketed molecules in the Global Venous thromboembolism (VTE) Market
- Global Epidemiology of Venous thromboembolism (VTE) Forecasted to 2020
- Global Market (2011-2015)
- Global Forecasted Market (2016-2020)
- Global Market by Geography
- Market of US (2011-2015)
- Forecasted Market of US (2016-2020)
- Market of Europe
- Market of Germany (2011-2015)
- Forecasted Market of Germany (2016-2020)
- Market of United Kingdom (2011-2015)
- Forecasted Market of United Kingdom (2016-2020)
- Market of France (2011-2015)
- Forecasted Market of France (2016-2020)
- Market of Italy (2011-2015)
- Forecasted Market of Italy (2016-2020)
- Market of Spain (2011-2015)
- Forecasted Market of Spain (2016-2020)
- Market of Japan (2011-2015)
- Forecasted Market of Japan (2016-2020)
- Market of ROW (2011-2015)
- Forecasted Market of ROW (2016-2020)
- Appendix
- Report Methodology
- Consulting Services
- Disclaimer
- Report Purchase Options
- About us

List of Tables

- Table 1: Drug Description
- Table 2: Drug, Marketed Details United States (US)
- Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
- Table 4: Drug, Patent Details for US
- Table 5: Venous thromboembolism (VTE) Drug Sales (USD Millions)-2020
- Table 6: Global Epidemiology of Venous thromboembolism (VTE) (2011-2020)
- Table 7: Venous thromboembolism (VTE) Global Market (USD Millions), (2011-2015)
- Table 8: Venous thromboembolism (VTE) Global Market (USD Millions), (2016-2020)
- Table 9: Venous thromboembolism (VTE) US Market (USD Millions), (2011-2015)
- Table 10: Venous thromboembolism (VTE) US Market (USD Millions), (2016-2020)
- Table 11: Venous thromboembolism (VTE) Germany Market (USD Millions), (2011-2015)
- Table 12: Venous thromboembolism (VTE) Germany Market (USD Millions), (2016-2020)
- Table 13: Venous thromboembolism (VTE) United Kingdom Market (USD Millions), (2011-2015)
- Table 14: Venous thromboembolism (VTE) United Kingdom Market (USD Millions), (2016-2020)
- Table 15: Venous thromboembolism (VTE) France Market (USD Millions), (2011-2015)
- Table 16: Venous thromboembolism (VTE) France Market (USD Millions), (2016-2020)
- Table 17: Venous thromboembolism (VTE) Italy Market (USD Millions), (2011-2015)
- Table 18: Venous thromboembolism (VTE) Italy Market (USD Millions), (2016-2020)
- Table 19: Venous thromboembolism (VTE) Spain Market (USD Millions), (2011-2015)
- Table 20: Venous thromboembolism (VTE) Spain Market (USD Millions), (2016-2020)
- Table 21: Venous thromboembolism (VTE) Japan Market (USD Millions), (2011-2015)
- Table 22: Venous thromboembolism (VTE) Japan Market (USD Millions), (2016-2020)
- Table 23: Venous thromboembolism (VTE) ROW Market (USD Millions), (2011-2015)
- Table 24: Venous thromboembolism (VTE) ROW Market (USD Millions), (2016-2020)

List of Figures

- Figure 1: Venous thromboembolism (VTE) Drug Sales (USD Millions)-2020
- Figure 2: Global Epidemiology of Venous thromboembolism (VTE) (2011-2020)
- Figure 3: Venous thromboembolism (VTE) Global Market (USD Millions), (2011-2015)
- Figure 4: Venous thromboembolism (VTE) Global Market (USD Millions), (2016-2020)
- Figure 5: Venous thromboembolism (VTE) US Market (USD Millions), (2011-2015)
- Figure 6: Venous thromboembolism (VTE) US Market (USD Millions), (2016-2020)
- Figure 7: Venous thromboembolism (VTE) Germany Market (USD Millions), (2011-2015)
- Figure 8: Venous thromboembolism (VTE) Germany Market (USD Millions), (2016-2020)
- Figure 9: Venous thromboembolism (VTE) United Kingdom Market (USD Millions), (2011-2015)
- Figure 10: Venous thromboembolism (VTE) United Kingdom Market (USD Millions), (2016-2020)
- Figure 11: Venous thromboembolism (VTE) France Market (USD Millions), (2011-2015)
- Figure 12: Venous thromboembolism (VTE) France Market (USD Millions), (2016-2020)
- Figure 13: Venous thromboembolism (VTE) Italy Market (USD Millions), (2011-2015)
- Figure 14: Venous thromboembolism (VTE) Italy Market (USD Millions), (2016-2020)
- Figure 15: Venous thromboembolism (VTE) Spain Market (USD Millions), (2011-2015)
- Figure 16: Venous thromboembolism (VTE) Spain Market (USD Millions), (2016-2020)
- Figure 17: Venous thromboembolism (VTE) Japan Market (USD Millions), (2011-2015)
- Figure 18: Venous thromboembolism (VTE) Japan Market (USD Millions), (2015-2020)
- Figure 19: Venous thromboembolism (VTE) ROW Market (USD Millions), (2011-2015)
- Figure 20: Venous thromboembolism (VTE) ROW Market (USD Millions), (2016-2020)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll